Trial Profile
PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2018
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms PREVENTIHS STUDY
- 23 Mar 2018 Status changed from recruiting to discontinued.
- 07 Mar 2018 New trial record